Seif Farhad, Khoshmirsafa Majid, Aazami Hossein, Mohsenzadegan Monireh, Sedighi Gholamreza, Bahar Mohammadali
ENT and Head and Neck Research Center and Department, Hazrat Rasoul Akram Hospital, Iran University of Medical Sciences, Tehran, Iran.
Department of immunology, school of medicine, Iran University of Medical Sciences, Tehran, Iran.
Cell Commun Signal. 2017 Jun 21;15(1):23. doi: 10.1186/s12964-017-0177-y.
The Janus kinase (JAK)-signal transducer and activator of transcription (STAT) pathway plays critical roles in orchestrating of immune system, especially cytokine receptors and they can modulate the polarization of T helper cells. This pathway is regulated by an array of regulator proteins, including Suppressors of Cytokine Signaling (SOCS), Protein Inhibitors of Activated STATs (PIAS) and Protein Tyrosine Phosphatases (PTPs) determining the initiation, duration and termination of the signaling cascades. Dysregulation of the JAK-STAT pathway in T helper cells may result in various immune disorders. In this review, we represent how the JAK-STAT pathway is generally regulated and then in Th cell subsets in more detail. Finally, we introduce novel targeted strategies as promising therapeutic approaches in the treatment of immune disorders. Studies are ongoing for identifying the other regulators of the JAK-STAT pathway and designing innovative therapeutic strategies. Therefore, further investigation is needed.
Janus激酶(JAK)-信号转导子和转录激活子(STAT)通路在协调免疫系统中发挥关键作用,尤其是在细胞因子受体方面,并且它们可以调节辅助性T细胞的极化。该通路由一系列调节蛋白调控,包括细胞因子信号抑制因子(SOCS)、活化STAT蛋白抑制剂(PIAS)和蛋白酪氨酸磷酸酶(PTP),这些蛋白决定了信号级联反应的起始、持续时间和终止。辅助性T细胞中JAK-STAT通路的失调可能导致各种免疫紊乱。在这篇综述中,我们首先阐述JAK-STAT通路的一般调控方式,然后更详细地介绍其在辅助性T细胞亚群中的调控情况。最后,我们介绍了作为治疗免疫紊乱有前景的治疗方法的新型靶向策略。目前正在进行研究以确定JAK-STAT通路的其他调节因子并设计创新的治疗策略。因此,需要进一步研究。